Carfilzomib
ATC L01XG02 · 10 markets · 35 records
Carfilzomib
Forms
ES 9 records · 3 strengths
AU 7 records · 4 strengths
- 30 mginjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial
- 60 mginjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial
- 10 mginjectionKYPROLISKYPROLIS carfilzomib 30 mg powder for injection vial
Records without a stated strength · 1 KYPROLIS
GB 4 records · 3 strengths
- 30 mginjectionKyprolis 60mg powder for solution for infusion vials
- 60 mginjectionKyprolis 60mg powder for solution for infusion vials
- 10 mginjectionKyprolis 60mg powder for solution for infusion vials
US 3 records · 3 strengths
CA 3 records · 3 strengths
TW 3 records · 2 strengths
- 30 mginjectionKyprolis forMyeloPro for Injection 30 mg、凱博斯凍晶注射劑30毫克、骨樂博凍晶注射劑30毫克
Records without a stated strength · 1 Kyprolis for injection、凱博斯凍晶注射劑
SG 2 records · 2 strengths
- 30 mginjectionKYPROLIS POWDER FOR SOLUTION FOR INFUSION 60MG/VIAL
- 60 mg/vialinjectionKYPROLIS POWDER FOR SOLUTION FOR INFUSION 60MG/VIAL
HK 2 records · 1 strengths
Records without a stated strength · 1 KYPROLIS FOR INJECTION 30MG/VIAL
CN 1 records · 1 strengths
- 60 mginjection凯洛斯卡非佐米
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 KYPROLIS
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.